These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 31533770)

  • 1. The role of age-specific N-terminal pro-brain natriuretic peptide cutoff values in predicting intravenous immunoglobulin resistance in Kawasaki disease: a prospective cohort study.
    Shao S; Luo C; Zhou K; Hua Y; Wu M; Liu L; Liu X; Wang C
    Pediatr Rheumatol Online J; 2019 Sep; 17(1):65. PubMed ID: 31533770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease.
    Yoshimura K; Kimata T; Mine K; Uchiyama T; Tsuji S; Kaneko K
    J Pediatr; 2013 Jun; 162(6):1205-9. PubMed ID: 23290510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
    Ye Q; Shao WX; Shang SQ; Zhang T; Hu J; Zhang CC
    Arthritis Rheumatol; 2015 Jul; 67(7):1943-50. PubMed ID: 25778686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
    Xie T; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F
    Pediatr Rheumatol Online J; 2017 Mar; 15(1):17. PubMed ID: 28320400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal pro-brain natriuretic peptide (NT proBNP) as a predictive indicator of initial intravenous immunoglobulin treatment failure in children with Kawasaki disease: a retrospective study.
    Kim SY; Han MY; Cha SH; Jeon YB
    Pediatr Cardiol; 2013; 34(8):1837-43. PubMed ID: 23744100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
    Kitoh T; Ohara T; Muto T; Okumura A; Baba R; Koizumi Y; Yamagishi Y; Mikamo H; Daigo K; Hamakubo T
    Front Immunol; 2021; 12():624802. PubMed ID: 33912155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A decision tree model for predicting intravenous immunoglobulin resistance and coronary artery involvement in Kawasaki disease.
    Joung J; Oh JS; Yoon JM; Ko KO; Yoo GH; Cheon EJ
    BMC Pediatr; 2022 Aug; 22(1):474. PubMed ID: 35931986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
    Huiling L; Yaping L; Xiufen H
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease.
    Reddy M; Singh S; Rawat A; Sharma A; Suri D; Rohit MK
    Rheumatol Int; 2016 Apr; 36(4):551-9. PubMed ID: 26849890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal pro-brain natriuretic peptide can be an adjunctive diagnostic marker of hyper-acute phase of Kawasaki disease.
    Kwon H; Lee JH; Jung JY; Kwak YH; Kim DK; Jung JH; Chang I; Kim K
    Eur J Pediatr; 2016 Dec; 175(12):1997-2003. PubMed ID: 27798729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of serum procalcitonin for both initial and repeated immunoglobulin resistance in Kawasaki disease: a prospective cohort study.
    Shao S; Luo C; Zhou K; Hua Y; Wu M; Liu L; Liu X; Wang C
    Pediatr Rheumatol Online J; 2019 Nov; 17(1):78. PubMed ID: 31775782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of Age-Stratified N-Terminal Prohormone of Brain Natriuretic Peptide for Diagnosing Kawasaki Disease.
    Lee SH; Song ES; Yoon S; Hong S; Cho HJ; Yang EM; Eom GH; Kang G; Cho YK
    Dis Markers; 2017; 2017():6263121. PubMed ID: 29358841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-type natriuretic peptide and N-terminal pro-BNP in the acute phase of Kawasaki disease.
    Iwashima S; Ishikawa T
    World J Pediatr; 2013 Aug; 9(3):239-44. PubMed ID: 23335186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors of resistance to intravenous immunoglobulin and coronary artery lesions in Kawasaki disease.
    Lee HY; Song MS
    Korean J Pediatr; 2016 Dec; 59(12):477-482. PubMed ID: 28194213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of the risk of coronary arterial lesions in Kawasaki disease by brain natriuretic peptide.
    Kaneko K; Yoshimura K; Ohashi A; Kimata T; Shimo T; Tsuji S
    Pediatr Cardiol; 2011 Dec; 32(8):1106-9. PubMed ID: 21487793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining the optimal cutoff values of plasma N-terminal pro-B-type natriuretic peptide levels for the diagnosis of heart failure in children of age up to 14 years.
    Lin CW; Zeng XL; Zhang JF; Meng XH
    J Card Fail; 2014 Mar; 20(3):168-73. PubMed ID: 24361777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of amino-terminal pro B-natriuretic peptide in diagnosing Kawasaki disease.
    McNeal-Davidson A; Fournier A; Spigelblatt L; Saint-Cyr C; Mir TS; Nir A; Dallaire F; Cousineau J; Delvin E; Dahdah N
    Pediatr Int; 2012 Oct; 54(5):627-33. PubMed ID: 22414326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease.
    Lu Y; Chen T; Wen Y; Si F; Wu X; Yang Y
    BMC Pediatr; 2021 Sep; 21(1):406. PubMed ID: 34530763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of IL-6, CRP and NT-proBNP levels in post-COVID multisystem inflammatory syndrome in children (MISC) and Kawasaki disease patients.
    Ganguly M; Nandi A; Banerjee P; Gupta P; Sarkar SD; Basu S; Pal P
    Int J Rheum Dis; 2022 Jan; 25(1):27-31. PubMed ID: 34750969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does N-terminal Pro-brain Type Natriuretic Peptide Predict Cardiac Complications After Hip Fracture Surgery?
    Ushirozako H; Ohishi T; Fujita T; Suzuki D; Yamamoto K; Banno T; Takase H; Matsuyama Y
    Clin Orthop Relat Res; 2017 Jun; 475(6):1730-1736. PubMed ID: 28101755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.